Viewing Study NCT00706134


Ignite Creation Date: 2025-12-25 @ 2:34 AM
Ignite Modification Date: 2025-12-26 @ 1:10 AM
Study NCT ID: NCT00706134
Status: COMPLETED
Last Update Posted: 2011-06-28
First Post: 2008-06-25
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: Efficacy and Safety of Aliskiren 75 mg, 150 mg, and 300 mg in Elderly Patients With Essential Hypertension When Given With a Light Meal in a 8 Week Placebo-controlled Study
Sponsor: Novartis
Organization: